Fortrea Holdings Inc. filings document the public-company disclosures of a Nasdaq-listed contract research organization. The company’s 8-K reports furnish operating results and financial condition updates, including revenue, profitability measures, book-to-bill metrics, guidance and related press release exhibits.
Fortrea’s regulatory filings also cover proxy governance, annual meeting matters, board composition, executive compensation and inducement award plans. Capital-structure disclosures include common stock, rights to purchase Series A preferred stock, senior secured notes activity and other debt or equity matters tied to the company’s clinical development services business.
Form 144 filed for Fortrea Holdings Inc. (FTRE) reports a proposed sale of 592 shares of common stock with an aggregate market value of $6,055.63. The filer acquired these shares on 09/08/2025 by restricted stock vesting from the issuer and lists the nature of payment as compensation. The filing identifies Fidelity Brokerage Services LLC as the broker and indicates an approximate sale date of 09/09/2025 on NASDAQ. The form notes there were no securities sold by the person in the past three months and includes the standard signer representation regarding material nonpublic information.
Fortrea Holdings Inc. (FTRE) filed a Form 144 to notify a proposed sale of common stock. The filer plans to sell 1,677 shares through Fidelity Brokerage Services with an aggregate market value of $17,154.20, representing part of 90,800,000 shares outstanding. The approximate sale date is 09/09/2025. The shares were acquired on 09/08/2025 through restricted stock vesting from the issuer and the payment is described as compensation. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
Fortrea Holdings (FTRE) Form 144 notice shows a proposed sale of 3,156 common shares through Fidelity Brokerage (Smithfield, RI) on 09/09/2025 with an aggregate market value of $32,283.04. The shares were acquired on 09/08/2025 as restricted stock vesting and paid as compensation. The filing reports 90,800,000 shares outstanding for the class. It also discloses a prior sale by Jill G. Mcconnell of 4,886 shares on 08/19/2025 for $39,160.31. The notice includes the signer’s representation that no undisclosed material adverse information exists.
Erin L. Russell, a director of Fortrea Holdings Inc. (FTRE), purchased 9,854 shares of the company's common stock on 09/02/2025 at a weighted average price of $10.15 per share. The Form 4 reports the shares as directly beneficially owned and notes the aggregate holding after the transaction is 9,854 shares. The filing states the trade was executed in multiple trades at prices ranging from $10.12 to $10.16 and that full trade details will be provided upon request. The Form 4 was signed by an attorney-in-fact for Ms. Russell.
Fortrea Holdings Inc. (FTRE) filed an S-8 registration that incorporates by reference its specified periodic and current reports, including quarterly reports for the periods ended March 31, 2025 and June 30, 2025 and several current reports filed on February 21, March 10, May 12, May 15, June 11, June 12 (two filings) and August 27, 2025. The filing also incorporates a description of the Company’s common stock from prior registration materials and explains that subsequently filed reports under specified Exchange Act sections will be deemed incorporated and may modify or supersede earlier statements.
The filing is a Form S-8 for Fortrea Holdings Inc. that incorporates prior SEC filings by reference rather than repeating them. Part I information is omitted per Form S-8 instructions. The statement lists specific documents incorporated by reference, including the 2024 annual report, specified quarterly reports for 2025, several current reports filed in 2025, and the Common Stock description from prior Form 10 exhibits. The filing limits incorporation to items "filed" with the Commission and excludes furnished-only documents.
Fortrea Holdings Inc. amended and restated its 2025 Inducement Award Plan on August 21, 2025 to increase the number of shares reserved for issuance by 2,200,000 shares. The amended and restated plan (the A&R Inducement Plan) expands the pool so the company can grant additional inducement awards to new hires who qualify under Nasdaq Listing Rule 5635(c)(4). The original 2025 Inducement Award Plan had been established solely to grant inducement awards to Anshul Thakral. The company will file the full text of the A&R Inducement Plan with its Quarterly Report for the quarter ending September 30, 2025.
Mark A. Morais, Chief Operating Officer of Fortrea Holdings Inc. (FTRE), reported settlement and related sales tied to time-vesting RSUs converted from Labcorp. On 08/18/2025, 11,312 Restricted Stock Units (RSUs) settled into Common Stock at $0 per share as scheduled following the Labcorp spin-off; those RSUs vested on 08/17/2025. On 08/19/2025 the reporting person sold 4,886 shares in a "sell to cover" required to satisfy tax withholding, executed in multiple trades at prices ranging from $7.89 to $8.10 with a weighted average of $8.01. Following these transactions the reporting person beneficially owned 52,975 shares directly and reported an indirect interest in 4,625 shares owned by a spouse, which were inadvertently omitted from prior filings.
Jill G. McConnell, Chief Financial Officer of Fortrea Holdings Inc. (FTRE), reported vesting and related sales of equity awards. On 08/18/2025 11,312 Restricted Stock Units (RSUs) settled into 11,312 shares of Fortrea common stock as scheduled. To satisfy tax withholding obligations, 4,886 shares were sold on 08/19/2025 at a weighted average price of $8.01 per share. After these transactions the reporting person beneficially owned 54,770 shares of common stock and held 91,805 RSUs.
Form 144 for Fortrea Holdings, Inc. (FTRE) shows a proposed sale of 4,886 common shares with an aggregate market value of $39,160.31, to be sold on or about 08/19/2025 through Fidelity Brokerage Services LLC on NASDAQ. The shares were acquired on 08/18/2025 upon restricted stock vesting and the payment type is listed as compensation. The filing reports 90,800,000 shares outstanding. It also discloses a prior sale by the same person of 3,130 shares on 06/03/2025 for $13,049.91. The filer certifies they are not aware of undisclosed material adverse information.